NantHealth Inc (NYSE:NH) shot up 4.5% on Friday . The company traded as high as $4.22 and last traded at $3.96. 191,222 shares changed hands during mid-day trading, a decline of 17% from the average session volume of 229,066 shares. The stock had previously closed at $3.79.

A number of research analysts recently issued reports on the company. BidaskClub upgraded NantHealth from a “strong sell” rating to a “sell” rating in a report on Friday. Jefferies Group LLC reiterated a “buy” rating and issued a $5.50 target price (down from $8.00) on shares of NantHealth in a report on Monday, June 19th. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $6.00 target price (down from $8.00) on shares of NantHealth in a report on Monday, August 21st. One equities research analyst has rated the stock with a sell rating and five have given a buy rating to the company. NantHealth has a consensus rating of “Buy” and an average target price of $8.55.

The stock’s 50-day moving average price is $3.60 and its 200-day moving average price is $4.13. The company’s market capitalization is $502.42 million.

NantHealth (NYSE:NH) last announced its quarterly earnings results on Thursday, August 10th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by $0.32. NantHealth had a negative net margin of 267.11% and a negative return on equity of 83.97%. The company had revenue of $26.23 million during the quarter, compared to analyst estimates of $31.28 million. During the same quarter in the prior year, the company posted ($0.15) earnings per share. The firm’s revenue for the quarter was down 16.7% on a year-over-year basis. Equities research analysts anticipate that NantHealth Inc will post ($0.70) EPS for the current year.

Several institutional investors have recently made changes to their positions in NH. Highbridge Capital Management LLC acquired a new stake in shares of NantHealth during the first quarter valued at about $998,000. National Planning Corp acquired a new stake in shares of NantHealth during the second quarter valued at about $473,000. Renaissance Technologies LLC acquired a new stake in shares of NantHealth during the first quarter valued at about $457,000. Northern Trust Corp grew its stake in shares of NantHealth by 133.9% during the second quarter. Northern Trust Corp now owns 151,907 shares of the company’s stock valued at $643,000 after acquiring an additional 86,955 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in shares of NantHealth by 91.5% during the second quarter. Goldman Sachs Group Inc. now owns 169,603 shares of the company’s stock valued at $717,000 after acquiring an additional 81,024 shares in the last quarter.

WARNING: “NantHealth Inc (NH) Shares Up 4.5%” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/09/08/nanthealth-inc-nh-shares-up-4-5.html.

NantHealth Company Profile

NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.